Lung cancer
A study to see the Genomic Signatures from lung tissue images using OncoPredikt an AI Platform in Lung Adenocarcinoma Patients.
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyStudy of how care is given
What it testsSurgery or a procedure
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Last updated on the registry 13 Oct 2025. Please confirm with the hospital that this trial is still taking patients.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Bhaktivedanta Hospital and Research InstituteMumbai, MaharashtraDirections ↗
Registry summary (technical)
A prospective, interventional, single center study to correlate outcomes using OncoPredikt,an (AI-enabled platform) to predict genomic signatures from histopathological images in lung adenocarcinoma patients. - NIL
Sponsor: OneCell Diagnostic India Pvt. Ltd
CTRI/2024/11/076681 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 13 Oct 2025 · read by us 5 Nov 2026